Sign in: Staff/Students
Professor Louise Kenny
Professor Louise Kenny, Executive Pro-Vice-Chancellor of the Faculty of Health and Life Sciences, will play a pivotal role in driving forward the vision of the Northern Health Science Alliance (NHSA) as she joins the leading life science cluster’s board.
Professor Kenny has been appointed to represent the North’s universities on the NHSA board of directors.
As a medic and leading professor, her health research and life sciences expertise across both academia and the NHS will strengthen the breadth of insight and knowledge on the NHSA board.
Her appointment comes following the start of multimillion-pound Research England-funded partnership project between the NHSA and MedCity earlier this year, which will improve the visibility of UK life sciences expertise on the international stage.
The NHSA is a partnership that links 10 universities and 10 research-intensive NHS Teaching Trusts with four Academic Health Science Networks across the North of England.
The organisation acts as a front door for northern health innovation, brokering research collaborations, attracting investment, and providing a unified voice for the region’s health research system.
Professor Kenny, said: “At a time when health research and innovation is front and centre in the fight against COVID-19, it’s more important than ever that the strengths of the North of England are showcased far and wide. The region has world-leading health assets, incredible talent and a passion for collaboration. The NHSA plays an important role in amplifying the North’s offer as it strives to bring investment and opportunities into the region for the benefit of the people and economy.
“I’m delighted to join the NHSA board as a representative of northern universities. I look forward to bringing my experience to the table to help shape the future of the organisation.”
Before moving to her current role at the University of Liverpool, Professor Kenny was Professor of Obstetrics and Gynaecology at Cork University Maternity Hospital where she worked as a Consultant Obstetrician and Gynaecologist for 12 years.
In 1998, she founded the Science Foundation Ireland (SFI) funded Irish Centre for Fetal and Neonatal Translational Research – Ireland’s first translational research centre focused entirely on pregnancy, birth and early childhood.
Professor David Burn, Chair of the NHSA board and Pro-Vice-Chancellor of the Faculty of Medical Sciences at Newcastle University, said: “We’re honoured to welcome Professor Kenny to the NHSA board.
“She is a respected and vastly experienced health and life science leader in the North and we will gain valuable insight from her as we continue to develop as a northern life sciences cluster and work towards our vision of improving the health and wealth of the region.”
Professor Kenny, who is also currently deputy Chair of the Board of Liverpool Health Partners, received her medical degree from the University of Liverpool in 1993 followed by a PhD from the University of Nottingham.
She replaces Professor Paul Stewart, Executive Dean of the Faculty of Medicine & Health and Dean of the Medical School at the University of Leeds, on the NHSA board.
She will join Professor Burn, Dr Séamus O’Neill, Chief Executive of the NHSA, Dr Liz Mear, Chief Executive Officer of the Innovation Agency North West Coast Academic Health Science Network, Dame Jackie Daniel, Chief Executive Officer of the Newcastle Hospitals NHS Foundation Trust, and three newly appointed non-executive directors Professor Sir John Tooke, Dr Kath Mackay and Dr Jonathan Sheffield OBE on the board NHSA board.
All recent news
New UK coronavirus measures introduced
Obituary: Dr Stephan Pfaffenzeller
Analysis reveals impact of poverty and family adversity on adolescent health
£1.6m study aims to understand why COVID-19 vaccines can lead to rare instances of blood clotting with low platelets
Arrangements for industrial action 1 – 3 December
Persistent poverty and/or persistent poor parental mental health affects over four in ten children in UK today, @LivUni-led analysis finds ➡️ https://bit.ly/3xButtM
£1.6m programme led by @MPUoL seeks to understand the very rare, but very serious, condition of blood clotting with low platelets in the general population, in #COVID19 infection & potentially following vaccination ➡️ https://bit.ly/3o5GtR1
Professor Tom Solomon, Director of the UK’s Emerging Infections Research Unit tells #BBCBreakfast more cases of Omicron are expected to be found in the UK.
Six more cases of the new coronavirus variant have been identified in Scotland.